CP
Chugai Pharma
Japan - Tokyo
PharmaceuticalFocus: Small Molecules
Chugai Pharma is a life sciences company focused on Small Molecules.
OncologyImmunologyNephrologyRare DiseasesGastroenterology
Employees
5000+
Open Jobs
0
Pipeline & Clinical Trials
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)
Non-small-Cell Lung CancerClinical Trials (1)
NCT03645330A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)
N/AEldecalcitol soft capsules
Postmenopausal OsteoporosisClinical Trials (1)
NCT05433207Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis
N/AErlotinib
Non Small Cell Lung CancerClinical Trials (1)
NCT00418704Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
N/AN/A
Clinical Trials (1)
NCT00144573Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
N/AAn Observational Study of Patients With Endometriosis to Evaluate the Usefulness of the MEDL Score,
EndometriosisClinical Trials (1)
NCT04846582An Observational Study of Patients With Endometriosis to Evaluate the Usefulness of the MEDL Score, a New Method for Evaluating Endometriosis Using MRI
N/ASpectra Optia® IDL-Set
Healthy Allogeneic DonorsClinical Trials (1)
NCT01901458Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®
N/AProspective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TA
Non-small Cell Lung CancerClinical Trials (1)
NCT04501497Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)
N/AN/A
Clinical Trials (1)
NCT00144560Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)
N/ANon-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Synd
Down SyndromeClinical Trials (1)
NCT02431117Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30
N/APatient Reported Outcomes Registry in Patient With Cancer Cachexia
Metastatic Pancreatic CancerClinical Trials (1)
NCT02983500Patient Reported Outcomes Registry in Patient With Cancer Cachexia
N/AAssessment of Giant Cell Arteritis Medical Practices in France
Giant Cell ArteritisClinical Trials (1)
NCT03658889Assessment of Giant Cell Arteritis Medical Practices in France
N/APD-L1 Expression in Japanese Renal Cell Carcinoma Patients
Renal Cell CarcinomaClinical Trials (1)
NCT03748901PD-L1 Expression in Japanese Renal Cell Carcinoma Patients
N/AStudy for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency
Rheumatoid ArthritisClinical Trials (1)
NCT02485483Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants
N/AObjective Pain Measurement Using a Wearable Biosensor and a Mobile Platform in Patients With Endomet
EndometriosisClinical Trials (1)
NCT04318275Objective Pain Measurement Using a Wearable Biosensor and a Mobile Platform in Patients With Endometriosis
N/Ano interventions
Severe Hemophilia AClinical Trials (1)
NCT05802836Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
N/ANon-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Ca
Non-small Cell Lung CancerClinical Trials (1)
NCT02968979Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.
N/AA Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With
Rheumatoid ArthritisClinical Trials (1)
NCT00661284A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)
N/AA Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptom
Celiac DiseaseClinical Trials (1)
NCT05686369A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study)
N/AQualitative Interview
Hemophilia A With InhibitorClinical Trials (1)
NCT04723693An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families
N/Aendoscopy
Chronic Kidney DiseasesClinical Trials (1)
NCT02539680Intestinal Phosphate Transporter Expression in CKD Patients
N/ACharacterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in R
Arthritis, RheumatoidClinical Trials (1)
NCT02569736Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation
N/AStudy of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthrit
Rheumatoid ArthritisClinical Trials (1)
NCT02251860Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice
N/AThe Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combi
Non-small Cell Lung CancerClinical Trials (1)
NCT04818983The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)
N/ADevelopment of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
LymphomaComorbidities treatment
Rheumatoid ArthritisClinical Trials (1)
NCT01315652Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial
N/APCO371
HealthyClinical Trials (1)
NCT02475616A Single Ascending Dose Study of PCO371 in Healthy Volunteers
Phase 1VS-6766
Solid TumoursClinical Trials (1)
NCT02407509Phase I Trial of VS-6766 Alone and in Combination With Everolimus
Phase 1Phase 1
Clinical Trials (1)
NCT00976170Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Phase 1PCO371
HypoparathyroidismClinical Trials (1)
NCT04209179A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism
Phase 1Phase 1
Clinical Trials (1)
NCT05022927A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma
Phase 1Phase 1
Clinical Trials (1)
NCT07107490A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase 1ROSE12
Solid TumorClinical Trials (1)
NCT05907980A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Phase 1Phase 1
Clinical Trials (1)
NCT06723106Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Phase 1Phase 1
Clinical Trials (1)
NCT04511845A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Phase 1RO7496353
Non-small Cell Lung CancerClinical Trials (1)
NCT05867121A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010
Phase 1Phase 1
Clinical Trials (1)
NCT06371417Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1GYM329
Healthy VolunteersClinical Trials (1)
NCT04708847A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer
Phase 1EOS789
HyperphosphatemiaClinical Trials (1)
NCT02965053A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
Phase 1PCO371
Healthy VolunteersClinical Trials (1)
NCT04649216Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371
Phase 1CH5132799
Solid TumorsClinical Trials (1)
NCT01222546Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors
Phase 1RO5126766
Advanced Non-small Cell Lung CancerClinical Trials (1)
NCT03681483RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
Phase 1Phase 1
Clinical Trials (1)
NCT00746317A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Phase 1Gantenerumab
Alzheimer's DiseaseClinical Trials (1)
NCT01656525A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients
Phase 1AUBE00
Solid TumorsClinical Trials (1)
NCT07030959Study of AUBE00 in Patients With Solid Tumors
Phase 1Phase 1
Clinical Trials (1)
NCT05012618A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Phase 1ERY974
Solid TumorsClinical Trials (1)
NCT02748837A Study of ERY974 in Patient With Advanced Solid Tumors
Phase 1Codrituzumab
Primary Extra-cranial Solid TumorClinical Trials (1)
NCT04928677A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
Phase 1Phase 1
Clinical Trials (1)
NCT00051779An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
Phase 1SAIL66
Solid TumorClinical Trials (1)
NCT05735366A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors
Phase 1Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2023
Portfolio: 139 clinical trials
Top TAs: Oncology, Immunology, Rare Diseases
Therapeutic Area Focus
Oncology
17 pipeline
Immunology
6 pipeline
Rare Diseases
6 pipeline
Ophthalmology
5 pipeline
Neurology
2 pipeline
Marketed
Pipeline